6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
ID: 36C77024Q0369Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/ba3d2ac698de42ce8880970d31f9b481/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.

    Point(s) of Contact
    Kelley CunninghamContract Specialist
    kelley.cunningham@va.gov
    Files
    Title
    Posted
    36C77024Q0369_1.docx
    The Department of Veterans Affairs (VA), through the Network Contracting Office 15, plans to procure Clofimehene Citrate tablets for delivery to the Lancaster CMOP facility in Texas. The presolicitation notice outlines the requirement for one pharmaceutical item, specifically 480 units of Clofimehene Citrate 50mg tablets, with a response deadline set for September 17, 2024. The procurement targets small businesses and emphasizes adherence to the Drug Supply Chain Security Act, requiring vendors to submit their state wholesale distributor licensure. Interested suppliers must submit their quotations via email and provide a signed solicitation cover page, a completed price schedule, their state license, and a Buy American Act certificate. This solicitation reflects the VA's ongoing commitment to ensuring a steady supply of pharmaceuticals to meet the needs of Veterans while supporting small business participation in federal contracting opportunities.
    36C77024Q0369.docx
    The document outlines a Request for Proposal (RFP) from the Department of Veterans Affairs for pharmaceutical supplies for the Consolidated Mail Outpatient Pharmacy (CMOP). It details the solicitation number, effective date, and contact information for submission. The acquisition is open to various types of small businesses, including women-owned and service-disabled veteran-owned businesses. Key provisions include specific delivery requirements, invoicing processes, and adherence to Federal Acquisition Regulations. Suppliers must ensure pharmaceutical products comply with shipping regulations (e.g., USPS-capable) and must provide documentation for drug supply chain security compliance. The proposal mandates bar code labeling on products and requires specific National Drug Codes (NDCs). The document emphasizes the importance of quality assurance throughout the procurement process, outlining expectations for product availability, acceptance, and recall notifications. Additionally, it includes clauses that enforce compliance with federal laws related to small business participation and regulations governing government contracts. Overall, this RFP exemplifies the federal government’s commitment to maintaining rigorous standards in procurement while promoting small business involvement.
    S02_Pricing Schedule_Q0369.xlsx
    The CMOP Lancaster RFQ 3677024Q0369 solicits quotes for pharmaceuticals and medical surgical supplies, with a delivery timeline of 10 days after receipt of order. Vendors must submit required documents, including a signed SF1449 cover page, an excel quote spreadsheet, a valid State Wholesale Distributor License, and a Buy American Act (BAA) certificate. The deadline for submissions is September 17, 2024, at 3:00 PM Central Time. Each vendor is limited to one proposal, and if proposing alternate NDCs, they must note any quantity adjustments in their submissions. The requirement mandates that pharmaceutical products must have a minimum shelf life of one year upon delivery, and vendors should specify expiration dates in their comments. The main item listed is Clomiphene Citrate 50mg tablets in a quantity of 480, with detailed documentation on NDCs, manufacturer information, and pricing required. The solicitation underscores the importance of compliance with federal standards and ensures that suppliers can meet urgent government health needs while maintaining quality and safety in pharmaceutical provisioning.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0108 770-25-1-801-0136 -National CMOP FENOFIBRATE 48mg
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate 48mg tablets for the National CMOP (Consolidated Mail Outpatient Pharmacy) facility. The solicitation, numbered 36C77025Q0108, requires vendors to provide specific quantities of the medication, with strict adherence to the Drug Supply Chain Security Act and the Buy American statute. This procurement is critical for ensuring the timely delivery of essential pharmaceuticals to veterans, with a closing date for submissions set for January 8, 2025, at 9:00 AM CST, and an estimated award date of January 13, 2025. Interested parties should submit their quotes and required documentation, including a signed SF1449 form and state wholesale distributor license, to Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Cyclobenzaprine HCL Tablets under solicitation number 36E79725R0009. This unrestricted procurement aims to secure a reliable supply of these essential pharmaceuticals for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC), reflecting the government's commitment to providing necessary medications to veterans and associated healthcare systems. The contract will have an initial duration of one year, with the possibility of four additional one-year extensions, and interested vendors must provide specific drug labeling along with a unique National Drug Code (NDC). The RFP is expected to be released electronically around December 20, 2024, with a submission deadline set for January 3, 2025. For further inquiries, interested parties can contact Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6505--Abiraterone Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the supply of Abiraterone Acetate Tablets through its Pharmaceutical Prime Vendor Program. Offerors are required to comply with the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP), providing a unique 11-digit National Drug Code (NDC) for each drug, along with pricing for the base year and four optional years, including a Cost Recovery Fee. This procurement is crucial for ensuring consistent availability and competitive pricing of essential medications for federal healthcare users, particularly veterans. Interested parties must submit their proposals by the extended deadline of January 8, 2025, at 2:30 PM CST, and can contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further information.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.
    Bicalutamide 50MG tablets
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is issuing a solicitation for a national requirements contract for Bicalutamide 50MG tablets, available in bottle counts of 30 and 500. The procurement aims to establish a reliable supply source for these pharmaceutical items, which are critical for various Department of Defense and other federal health programs, including the Department of Veterans Affairs and the Indian Health Service. This unrestricted and fully competitive acquisition will be a firm-fixed price contract with a one-year base and four one-year options, with proposals due by January 24, 2025. Interested parties can reach out to Keith Ryales at keith.ryales@dla.mil or 215-737-9199 for further inquiries and are encouraged to monitor the DLA Bid Board System and SAM.gov for updates on the solicitation.
    6505--Carbidopa/Levodopa SA Tablet
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) 36E79725R0008 for the procurement of Carbidopa/Levodopa sustained release (SA) tablets, aimed at ensuring a continuous supply of these medications for various federal health services, including the Department of Defense and the Bureau of Prisons. The contract will be awarded for an initial period of one year, with the option to extend for four additional one-year periods, requiring offerors to provide unique branding and packaging without overlapping labels. The estimated annual usage totals approximately 119,875 bottles across two dosage forms, highlighting the importance of these medications in treating Parkinson's disease and related conditions. Interested parties should note that the electronic solicitation is expected to be issued around January 3, 2026, with offers due by January 17, 2026; questions can be directed to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov.
    6505--Nadolol Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0014 concerning the procurement of Nadolol Tablets. This procurement aims to secure an uninterrupted supply of Nadolol Tablets for various federal health entities, including the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service, with a contract period of one year and four optional one-year extensions. The estimated annual requirements include approximately 7,753 bottles of 20MG, 6,085 bottles of 40MG, and 1,566 bottles of 80MG tablets, all of which must feature unique labeling (NDC number) as specified. The solicitation is expected to be released electronically on or around January 10, 2025, with responses due by January 27, 2025. Interested suppliers can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov.
    6505--Metformin IR Tablets - REPACK PROGRAM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Metformin HCL IR Tablets under solicitation number 36E79725R0013. This procurement aims to ensure a consistent supply of Metformin for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center, with a contract term of one year and four optional annual extensions. The successful bidders must provide unique drug labeling with a distinct National Drug Code (NDC), as the packaging must exclusively display the contractor's label without overlapping with others. The solicitation is expected to be released electronically on January 21, 2025, with a submission deadline of February 4, 2025. Interested parties can direct inquiries to Contracting Officer Teresa Hussain at teresa.hussain@va.gov or by phone at 708-786-5852.